Thrombin Generation in Neonatal Plasma After Cardiopulmonary Bypass
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The primary goal of this investigation is to determine the ability of recombinant activated
factor VII (rFVIIa) and prothrombin complex concentrate (PCC) to improve thrombin generation
in neonatal plasma after CPB.